BRD4 and Cancer: going beyond transcriptional regulation

被引：0
|
作者：
Benedetta Donati
Eugenia Lorenzini
Alessia Ciarrocchi
机构：
[1] Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia,Laboratory of Translational Research
来源：
Molecular Cancer | / 17卷
关键词：
BRD4; BET inhibitors; Transcriptional regulation; DNA damage response; Telomere regulation; Unconventional function; Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
BRD4, member of the Bromodomain and Extraterminal (BET) protein family, is largely acknowledged in cancer for its role in super-enhancers (SEs) organization and oncogenes expression regulation. Inhibition of BRD4 shortcuts the communication between SEs and target promoters with a subsequent cell-specific repression of oncogenes to which cancer cells are addicted and cell death. To date, this is the most credited mechanism of action of BET inhibitors, a class of small molecules targeting BET proteins which are currently in clinical trials in several cancer settings.
引用
收藏
相关论文
共 50 条
  • [31] Dual HDAC/BRD4 inhibitors against cancer
    Negar Omidkhah
    Farzin Hadizadeh
    Razieh Ghodsi
    Medicinal Chemistry Research, 2021, 30 : 1822 - 1836
  • [32] Brd4 and HEXIM1: Multiple Roles in P-TEFb Regulation and Cancer
    Chen, Ruichuan
    Yik, Jasper H. N.
    Lew, Qiao Jing
    Chao, Sheng-Hao
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [33] SLAM-SEQ IDENTIFIES DIRECT TRANSCRIPTIONAL TARGETS OF BRD4 AND MYC
    不详
    CANCER DISCOVERY, 2018, 8 (06) : 671 - 671
  • [34] BRD4 is a newly characterized transcriptional regulator that represses autophagy and lysosomal function
    Wen, Xin
    Klionsky, Daniel J.
    AUTOPHAGY, 2017, 13 (11) : 1801 - 1803
  • [35] BRD4 interacts with NIPBL and BRD4 is mutated in a Cornelia de Lange–like syndrome
    Gabrielle Olley
    Morad Ansari
    Hemant Bengani
    Graeme R. Grimes
    James Rhodes
    Alex von Kriegsheim
    Ana Blatnik
    Fiona J. Stewart
    Emma Wakeling
    Nicola Carroll
    Alison Ross
    Soo-Mi Park
    Wendy A. Bickmore
    Madapura M. Pradeepa
    David R. FitzPatrick
    Nature Genetics, 2018, 50 : 329 - 332
  • [36] Identification of selective Brd4 degrader for cancer treatment.
    Hu, Biao
    Hu, Jiantao
    Xu, Fuming
    Huang, Liyue
    Wang, Mi
    Wang, Shaomeng
    CANCER RESEARCH, 2021, 81 (13)
  • [37] The Long and the Short of BRD4: Two Tales in Breast Cancer
    Zhang, Sicong
    Roeder, Robert G.
    MOLECULAR CELL, 2020, 78 (06) : 993 - 995
  • [38] BRD4 Inhibitor Inhibits Colorectal Cancer Growth and Metastasis
    Hu, Yuan
    Zhou, Jieqiong
    Ye, Fei
    Xiong, Huabao
    Peng, Liang
    Zheng, Zihan
    Xu, Feihong
    Cui, Miao
    Wei, Chengguo
    Wang, Xinying
    Wang, Zhongqiu
    Zhu, Hongfa
    Lee, Peng
    Zhou, Mingming
    Jiang, Bo
    Zhang, David Y.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (01): : 1928 - 1948
  • [39] Transcriptional regulation of hexokinase 2 by BRD4 drives perivascular adipose tissue meta-inflammation in cardiometabolic disease
    Mengozzi, A.
    Costantino, S.
    Mongelli, A.
    Duranti, E.
    Mohammed, S. A.
    Gorica, E.
    Telesca, M.
    Armenia, S.
    Cappelli, F.
    Matter, C. M.
    Taddei, S.
    Masi, S.
    Ruschitzka, F.
    Virdis, A.
    Paneni, F.
    CARDIOVASCULAR RESEARCH, 2024, 120
  • [40] Brd4 Regulation of Papillomavirus Protein E2 Stability
    Zheng, Gang
    Schweiger, Michal-Ruth
    Martinez-Noel, Gustavo
    Zheng, Leon
    Smith, Jennifer A.
    Harper, J. Wade
    Howley, Peter M.
    JOURNAL OF VIROLOGY, 2009, 83 (17) : 8683 - 8692
12345